Media - Abzena

Events

Antibody Engineering and Therapeutics

9 December 2019

The largest meeting bringing you the latest antibody science, technologies and partners needed to accelerate next[...] Read more

PEGS Europe Lisbon

18 November 2019

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2018, more than[...] Read more

References

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more

News

Sonnet BioTherapeutics selects Abzena as clinical stage manufacturing partner for its IL-12-FHAB cytokine-derived therapeutic candidate

PRINCETON, NJ and San Diego, CA, USA 22 October 2019 – Sonnet BioTherapeutics Inc., a clinical stage biopharmaceutical[...] Read more

Abzena Names Kimball Hall as Chief Operating Officer

Abzena announced today the appointment of Kimball Hall as Chief Operating Officer, adding to the company’s executive[...] Read more

Posts

We’re changing the way we brand our businesses

To provide our Partners with a single identity for the services and technologies offered across Antitope, PacificGMP,[...] Read more

Interested in our services? Get In Touch